阿米奥达龙诱导的甲状腺毒性:应该考虑手术吗?
Samuel Frey1, Cécile Caillard2, Pascale Mahot3
1Nantes université, CHU de Nantes, chirurgie cancérologique, digestive et endocrinienne, institut des maladies de l'appareil digestif, 44000 Nantes, France; Institut du thorax, CHU de Nantes, CNRS, Nantes université, Inserm, 44000 Nantes, France.
Annales d'endocrinologie
|January 21, 2024
概括
阿米奥达龙诱导的甲状腺毒毒症影响15-20%的患者. 对于那些对药物无反应或射出分数低的人来说,建议早期手术,提供与其他甲状腺切除术相似的安全性.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 甲状腺学 甲状腺学
背景情况:
- 艾米奥达龙是一种常见的抗心律失常药,在15-20%的使用者中引起胆固醇毒性.
- 来自阿米奥达龙的甲状腺毒性症呈现为甲状腺功能障碍或甲状腺功能障碍.
- 诊断包括低TSH和高T3/T4水平.
研究的目的:
- 审查阿米奥达龙诱导的甲状腺毒性病 (AIT).
- 分析外科手术对AIT的影响.
- 为特定的AIT患者群体提出早期手术作为主要治疗选择.
主要方法:
- 关于阿米奥达龙诱导的甲状腺毒性病的文献综述.
- 对AIT手术的疗效和安全性现有研究的分析.
- 对AIT患者心血管不良事件的预测因素的评估.
主要成果:
- 阿米奥达龙诱导的甲状腺毒性需要谨慎管理.
- 医疗治疗可能对某些患者无效.
- 低左心室射出分数和诊断到甲状腺功能延长的间隔预测不良心血管事件.
结论:
- 对于没有有效的医疗治疗或左心室喷射率<40%的患者,应考虑早期手术干预.
- 专家中心的手术发病率与其他甲状腺切除术指示相比较.
- 手术为耐火性阿米奥达龙诱导的甲状腺毒性提供了及时的解决方案.
相关概念视频
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.0K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.0K
Heart Failure Drugs: Inotropic Agents
591
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
591
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Disturbances in Heart Rhythm
961
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
961


